- Home
- STSS vs IMCC Comparison
STSS vs IMCC Comparison
Compare STSS & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- IMCC
- Stock Information
- Founded
- STSS 2017
- IMCC 1980
- Country
- STSS United States
- IMCC Israel
- Employees
- STSS N/A
- IMCC N/A
- Industry
- STSS Medical/Dental Instruments
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- STSS Health Care
- IMCC Health Care
- Exchange
- STSS Nasdaq
- IMCC Nasdaq
- Market Cap
- STSS 4.6M
- IMCC 5.3M
- IPO Year
- STSS 2022
- IMCC N/A
- Fundamental
- Price
- STSS $5.87
- IMCC $2.76
- Analyst Decision
- STSS
- IMCC
- Analyst Count
- STSS 0
- IMCC 0
- Target Price
- STSS N/A
- IMCC N/A
- AVG Volume (30 Days)
- STSS 2.6M
- IMCC 632.5K
- Earning Date
- STSS 05-15-2025
- IMCC 05-15-2025
- Dividend Yield
- STSS N/A
- IMCC N/A
- EPS Growth
- STSS N/A
- IMCC N/A
- EPS
- STSS N/A
- IMCC N/A
- Revenue
- STSS N/A
- IMCC $37,894,737.00
- Revenue This Year
- STSS N/A
- IMCC $47.12
- Revenue Next Year
- STSS N/A
- IMCC $12.83
- P/E Ratio
- STSS N/A
- IMCC N/A
- Revenue Growth
- STSS N/A
- IMCC 12.68
- 52 Week Low
- STSS $3.36
- IMCC $1.29
- 52 Week High
- STSS $2,904.00
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- STSS 42.25
- IMCC 52.50
- Support Level
- STSS $3.44
- IMCC $2.55
- Resistance Level
- STSS $7.04
- IMCC $7.12
- Average True Range (ATR)
- STSS 0.51
- IMCC 1.08
- MACD
- STSS 1.33
- IMCC 0.01
- Stochastic Oscillator
- STSS 67.47
- IMCC 21.85
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.